MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2018 International Congress

    Assessing the Effectiveness of Valbenazine in the Treatment of Tardive Dyskinesia as Determined by the AIMS and PGIC: Results from the KINECT 4 Trial

    C. Singer, C. Comella, K. Farahmand, J. Burke, R. Jimenez, S. Siegert (Miami, FL, USA)

    Objective: To assess the long-term effects of once-daily valbenazine on tardive dyskinesia (TD). Background: Valbenazine has been evaluated in several long-term TD studies, including the…
  • 2018 International Congress

    Demographic and Clinical Characteristics of Flunarizine Induced Parkinsonism: Nationwide Data Between 2000 and 2006 in Taiwan

    W. Lin, CY. Wei, HJ. Chen (ChangHua, Taiwan)

    Objective: The calcium channel blockers, such as flunarizine and cinnarizine, and rarely selective serotonin reuptake inhibitors and lithium can produce parkinsonism and tardive syndromes. Background:…
  • 2018 International Congress

    An evaluation of the availability and format of information provided to patients who have a new diagnosis of Parkinson’s disease (PD)

    L. Ebenezer, J. Price, H. Martin (Bridgend, United Kingdom)

    Objective: To evaluate if the information provided to a person with Parkinson’s (PwP) is relevant and appropriate for that individual. To also consider the need…
  • 2018 International Congress

    Inherited neuromyotonia associated with a dominant-negative KCNQ2 mutation

    Y.T. Hsu, W.D. Lin, Y.W. Yang, D.C. Wu, C.H. Tsai (Taichung, Taiwan)

    Objective: To report the phenotypic and genotypic characteristics of a Taiwanese family with inherited neuromyotonia associated with KCNQ2 mutation. Background: Neuromyotonia is a disorder of…
  • 2018 International Congress

    Genetic analysis of Wilson’s disease in Taiwan

    T.H. Yeh, C.S. Lu, C.C. Huang, S.C. Lai (Taipei, Taiwan)

    Objective: Genetic analysis of Taiwanese patients with Wilson’s disease. Background: Wilson’s disease (WD) is an autosomal recessive disorder of copper metabolism. The genetic cause is…
  • 2018 International Congress

    Reversible asymmetric parkinsonism and vertical gaze limitation as an initial manifestation of dural arteriovenous fistula

    W. Yoon (Seoul, Republic of Korea)

    Objective: Our aim is to report a case of unusual manifestation of dural arteriovenous fistula (DAVF) which showed reversible asymmetric parkinsonism and vertical gaze limitation…
  • 2018 International Congress

    Comparison of Volumetric MRI measurements between Dementia with Lewy bodies and prodromal Lewy body disease

    B. Tousi, F. Flanigan, k. Khosravi (Cleveland, OH, USA)

    Objective: To compare the volumetric changes between patients at prodromal stage of Lewy body disese and individuals with dementia with Lewy Bodies. Background: Volumetric magnetic…
  • 2018 International Congress

    Neuromodulatory propensity of Ginko biloba to offset rotenone induced behaviour and biochemical alteration

    K. Rode, D. Khatri, M. Panchawadkar, P. Rane (Pune, India)

    Objective: The aim of present study was to evaluate neuromodulatory propensity of Gingko Biloba in rotenone induced Mice Model of Parkinson Disease in terms of…
  • 2018 International Congress

    Distinct abnormality of movement-related cortical potential between patients with Holmes tremor and cerebellar degeneration

    M.K. Lu, J.C. Chen, S.M. Liu, C.H. Tsai (Taichung, Taiwan)

    Objective: This study aims to investigate the role of cerebellum and the olivodentatorubral pathway in generating movement-related cortical potential (MRCP). Background: Cerebellum and its connecting…
  • 2018 International Congress

    The Impact of Vocal Fold Augmentation with Injection Laryngoplasty on Voice Quality in Patients with Parkinson Disease

    O. Klepitskaya, J. Barr, Y. Liu, S. Sillau, J. Litts, D. Fink, M. Shaffer, J. Newcombe, A. Klepitskaya, M. Clary (Aurora, CO, USA)

    Objective: To evaluate the effect of vocal fold injection augmentation with a temporary filler (carboxymethylcellulose gel) on voice and speech in Parkinson Disease (PD) patients…
  • « Previous Page
  • 1
  • …
  • 54
  • 55
  • 56
  • 57
  • 58
  • …
  • 177
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley